2018
DOI: 10.1186/s12879-018-3277-4
|View full text |Cite
|
Sign up to set email alerts
|

Bilateral osteomyelitis and liver abscess caused by hypervirulent Klebsiella pneumoniae- a rare clinical manifestation (case report)

Abstract: BackgroundHypervirulent strains of Klebsiella pneumoniae are a recognized cause of a distinct invasive syndrome that results in pyogenic liver abscesses and metastatic complications, particularly in the Asia Pacific region. Reports of hypervirulent K.pneumoniae in Europe, the Americas and Australia indicate worldwide spread. We present a case of multi-focal osteomyelitis, a rarely described complication of hypervirulent K.pneumoniae in the medical literature. The prevalence of this condition in countries outsi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
20
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 29 publications
1
20
0
Order By: Relevance
“…Global dissemination of hvKp. Following early reports of hvKp in Asia, it is now apparent that hvKp has spread globally, including India [163,164], Europe [32,34,35,37,[165][166][167][168], Australia [169,170] and the United States [5,30,31,36,53,171,172] and healthcare providers worldwide should recognize the threat of community-acquired hvKp in otherwise healthy individuals. The rise of hospital-acquired hvKp which may manifest in different presentations, and the convergence of multidrug resistance (MDR) and virulence either in as well as bla SHV-1 and fosA [182] AR, antimicrobial resistance; bla, beta-lactamase provides resistance to penicillins, first-and second-generation cephalosporins; bla CTX-M-24, bla CTX-M-3 and bla CTX-M-4 , ESBLs with particular activity against cefotaxime; bla KPC-2, bla (K. pneumoniae carbapenem resistance) with carbapenemase activity; bla NDM-1 , bla (New Delhi metallo-bla) with carbapenemase activity; bla OXA-32 and bla OXA-9 , ESBLs with particular activity against oxacillin; bla SHV-36 and bla SHV-11 , ESBLs; bla TEM-1A, bla TEM-1, and bla TEM-53 , ESBLs; dfrA14, trimethoprim resistance gene; ESBL, extended-spectrum betalactamase provides additional resistance to monobactams and third-generation cephalosporins; fosA, fosfomycin resistance gene; kb, kilobase, length of DNA molecule; ompK35/36, outer membrane porins that allow entry carbapenems and cephalosporins, reduced expression increases resistance; oqxAB, resistance to olaquindox and some quinolones.…”
Section: Outstanding Questions and Outlookmentioning
confidence: 99%
See 1 more Smart Citation
“…Global dissemination of hvKp. Following early reports of hvKp in Asia, it is now apparent that hvKp has spread globally, including India [163,164], Europe [32,34,35,37,[165][166][167][168], Australia [169,170] and the United States [5,30,31,36,53,171,172] and healthcare providers worldwide should recognize the threat of community-acquired hvKp in otherwise healthy individuals. The rise of hospital-acquired hvKp which may manifest in different presentations, and the convergence of multidrug resistance (MDR) and virulence either in as well as bla SHV-1 and fosA [182] AR, antimicrobial resistance; bla, beta-lactamase provides resistance to penicillins, first-and second-generation cephalosporins; bla CTX-M-24, bla CTX-M-3 and bla CTX-M-4 , ESBLs with particular activity against cefotaxime; bla KPC-2, bla (K. pneumoniae carbapenem resistance) with carbapenemase activity; bla NDM-1 , bla (New Delhi metallo-bla) with carbapenemase activity; bla OXA-32 and bla OXA-9 , ESBLs with particular activity against oxacillin; bla SHV-36 and bla SHV-11 , ESBLs; bla TEM-1A, bla TEM-1, and bla TEM-53 , ESBLs; dfrA14, trimethoprim resistance gene; ESBL, extended-spectrum betalactamase provides additional resistance to monobactams and third-generation cephalosporins; fosA, fosfomycin resistance gene; kb, kilobase, length of DNA molecule; ompK35/36, outer membrane porins that allow entry carbapenems and cephalosporins, reduced expression increases resistance; oqxAB, resistance to olaquindox and some quinolones.…”
Section: Outstanding Questions and Outlookmentioning
confidence: 99%
“…Global dissemination of hvKp. Following early reports of hvKp in Asia, it is now apparent that hvKp has spread globally, including India , Europe , Australia and the United States and healthcare providers worldwide should recognize the threat of community‐acquired hvKp in otherwise healthy individuals. The rise of hospital‐acquired hvKp which may manifest in different presentations, and the convergence of multidrug resistance (MDR) and virulence either in cKp or hvKp strains, is particularly concerning.…”
Section: Outstanding Questions and Outlookmentioning
confidence: 99%
“…Moreover it is well-established that strains from the most virulent K. pneumoniae sequence type ST23 remain less resistant to antibiotics -primarily to fluoroquinolonesthan isolates from the MDR major international STs (Cejas et al, 2014;Qu et al, 2015;Cheong et al, 2016;Yan et al, 2016;Chen Y.T. et al, 2017;Ku et al, 2017;Lu et al, 2017;Sturm et al, 2018;Shen et al, 2019). Moreover, similarly to the most virulent MRSA clone, ST121, no high-level resistance to fluoroquinolones has been reported in any ST23 K. pneumoniae strain to date.…”
Section: The Virulence Component In Mdr K Pneumoniaementioning
confidence: 99%
“…Although there is no established definition of KPIS [7,8], it is classically described as a clinical syndrome rotizing fasciitis [36], vertebral discitis [37], multifocal osteomyelitis [38], prostate abscess [39], splenic, neck, cerebral, and psoas muscle abscesses, otitis media, and arthritis [40]. In our case, the patient presented with liver abscess and septic pulmonary embolism which is considered in the literature as a rare extrahepatic complication [41].…”
Section: Discussionmentioning
confidence: 79%